Search Orphan Drug Designations and Approvals
-
Generic Name: | solnatide |
---|---|
Date Designated: | 02/04/2016 |
Orphan Designation: | Treatment of primary graft dysfunction following lung transplantation |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Apeptico Forschung und Entwicklung GmbH c/o mingo bueros Vienna Austria The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-